Ozempic cuts drinking, Zepbound beats Wegovy, and a blood test detects 50 cancers: Pharma news roundup

Some patients taking weight-loss drugs, including popular GLP-1 treatments like Ozempic (NVO) and Wegovy, reported reducing their consumption of alcohol, according to a new study published recently in the scientific journal JAMA Network Open. Eli Lilly released results this week of a clinical trial comparing its…

Read more...